Interestingly, we moreover demonstrate that the phosphomimetic MYD88 S257D promotes aggregation, phosphorylation, and NF-κB activation in DLBCL with a similar efficacy, hence mimicking the functional effects of the oncogenic mutant (Fig. 2 and Fig. 3). The gene discussed is MYD88; the disease is diffuse large B-cell lymphoma.